ANDREW RAPPAPORT

Insider Reports History

Signature
/s/ Shane Kovacs, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANDREW RAPPAPORT:

Company Role Class Num Shares Value Price $ Report Date Ownership
Olema Pharmaceuticals, Inc. Director Common Stock 385,965 $3,392,632 $8.79 21 Nov 2025 Indirect
Olema Pharmaceuticals, Inc. Director Common Stock 0 $0 $8.79 25 Nov 2025 Direct
Olema Pharmaceuticals, Inc. Director Stock Option (right to buy) 0 21 Nov 2025 Direct

Insider Reports Filed by ANDREW RAPPAPORT

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OLMA Olema Pharmaceuticals, Inc. 21 Nov 2025 3 +$13,989 4 Director 25 Nov 2025, 18:00
OLMA Olema Pharmaceuticals, Inc. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 17:00
OLMA Olema Pharmaceuticals, Inc. 14 Jun 2024 1 $0 4 Director 18 Jun 2024, 17:00
OLMA Olema Pharmaceuticals, Inc. 05 Mar 2024 2 $0 4 Director 06 Mar 2024, 17:36
OLMA Olema Pharmaceuticals, Inc. 16 Jun 2023 1 $0 4 Director 21 Jun 2023, 17:00
OLMA Olema Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4/A Director 27 Jun 2022, 17:06
OLMA Olema Pharmaceuticals, Inc. 16 Jun 2022 1 $0 4 Director 17 Jun 2022, 19:27
OLMA Olema Pharmaceuticals, Inc. 09 Jun 2021 1 $0 4 Director 10 Jun 2021, 18:35